Skip to main content

Alavert: Package Insert / Prescribing Info

Package insert / product label
Generic name: loratadine
Dosage form: tablet, orally disintegrating
Drug class: Antihistamines

Medically reviewed by Drugs.com. Last updated on Mar 25, 2024.

ACTIVE INGREDIENT (IN EACH TABLET)

Loratadine 10 mg

PURPOSE

Antihistamine

Indications and Usage for Alavert

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

do not use more than directed. Taking more than recommended may cause drowsiness.

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Alavert Dosage and Administration

  • tablet melts in mouth. Can be taken with or without water.
AgeDose

adults and children 6 years and over

1 tablet daily; do not use more than 1 tablet daily

children under 6

ask a doctor

consumers who have liver or kidney disease

ask a doctor

OTHER INFORMATION

  • Phenylketonurics:Contains Phenylalanine 8.4 mg per tablet
  • store at 20-25ºC (68-77ºF)
  • keep in a dry place

INACTIVE INGREDIENTS

Alavert Allergy Fresh Mint

anhydrous citric acid, aspartame, colloidal silicon dioxide, corn syrup solids, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

Alavert Allergy Citrus Burst

anhydrous citric acid, aspartame, butylated hydroxyanisole, colloidal silicon dioxide, corn syrup solids, crospovidone, dextrin, ferric oxides, magnesium stearate, maltodextrin, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

QUESTIONS OR COMMENTS?

call weekdays from 9 AM to 5 PM EST at 1-800-ALAVERT (1-800-252-8378)

PRINCIPAL DISPLAY PANEL

The product packaging shown below represents a sample of that currently in use. Additional packaging may also be available.

ALAVERT allergy Fresh Mint

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itching of Nose & Throat

Compare to Claritin †& SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Fresh Mint Packaging

PRINCIPAL DISPLAY PANEL

ALAVERT allergy Citrus Burst

Loratadine Orally Disintegrating Tablet, 10 mg, Antihistamine

18 Orally Disintegrating Tablets

TASTES GREAT!

Melts in your Mouth!

Non-Drowsy* Allergy Relief

*When taken as directed. See Drug Facts Panel.

24 HOUR Relief of

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itching of Nose & Throat

Compare to Claritin† & SAVE!

†Claritin is a registered trademark of Schering Corporation

Alavert Allergy Citrus Burst Packaging
ALAVERT ALLERGY
loratadine tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0573-2620
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
ASPARTAME (UNII: Z0H242BBR1)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CORN SYRUP (UNII: 9G5L16BK6N)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MANNITOL (UNII: 3OWL53L36A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM BICARBONATE (UNII: 8MDF5V39QO)
Product Characteristics
Colorwhite (off white) Scoreno score
ShapeROUND (beveled tablet) Size14mm
FlavorMINTImprint CodeA;24
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0573-2620-1918 in 1 CARTON12/19/2002
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:0573-2620-0150 in 1 BOX12/19/2002
21 in 1 POUCH; Type 0: Not a Combination Product
3NDC:0573-2620-6560 in 1 CARTON12/19/2002
31 in 1 BLISTER PACK; Type 0: Not a Combination Product
4NDC:0573-2620-711500 in 1 BOX12/19/2002
41 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02137512/19/2002
ALAVERT ALLERGY
loratadine tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0573-2621
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
ASPARTAME (UNII: Z0H242BBR1)
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CORN SYRUP (UNII: 9G5L16BK6N)
CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)
ICODEXTRIN (UNII: 2NX48Z0A9G)
FERRIC OXIDE RED (UNII: 1K09F3G675)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
MANNITOL (UNII: 3OWL53L36A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM BICARBONATE (UNII: 8MDF5V39QO)
Product Characteristics
Colororange (an orange flat faced tablet) Scoreno score
ShapeROUND (beveled tablet) Size14mm
FlavorCITRUS (orange mint) Imprint CodeA;24
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0573-2621-6560 in 1 CARTON12/19/2002
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:0573-2621-1918 in 1 CARTON12/19/2002
21 in 1 BLISTER PACK; Type 0: Not a Combination Product
3NDC:0573-2621-1312 in 1 CARTON12/19/2016
31 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02137512/19/2002
Labeler - Haleon US Holdings LLC (079944263)

Frequently asked questions

Medical Disclaimer